Myopericaditis as a late manifestation of the probable COVID-19
https://doi.org/10.18087/cardio.2020.8.n1232
Abstract
The article describes a clinical case of myopericarditis as a late manifestation of possible COVID-19.
About the Authors
L. N. ChikhirevaRussian Federation
c.m.s., cardiologist of the Follow-up department
O. A. Chikhirev
Russian Federation
c.m.s., Нead of Сardiology department
D. A. Pikin
Russian Federation
c.m.s., Нead of the Follow-up department
O. P. Bychkova
Russian Federation
Head of the department of Functional Diagnostics
A. M. Cherkashov
Russian Federation
Corresponding Member of Russian Academy of Natural Sciences, MD, PhD, Head Physician of the Multidisciplinary Medical Center of the Bank of Russia
Yu. N. Belenkov
Russian Federation
Academician of Russian Sciences Academy, MD, PhD, Head of Hospital Therapy Department Pervyj Moskovskij gosudarstvennyj medicinskij universitet imeni I. M. Secenova
References
1. Promed Post – ProMED-mail. Published Date: 2019-12-30 23:59:00. Subject: PRO/AH/EDR> Undiagnosed pneumonia - China (HU): RFI. Archive Number:20191230.6864153. Av. at: https://promedmail.org/promed-post/?id=6864153.
2. Federal Service for Surveillance on Consumer, Rights Protection and Human Wellbeing. About the confirmed case of a new coronavirus infection COVID-2019 in Russia. 2020. [Internet] 2020. Available at: https://www.rospotrebnadzor.ru/about/info/news/news_details.php?ELEMENT_ID=13870
3. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine. 2020;382(18):1708–20. DOI: 10.1056/NEJMoa2002032
4. Glybochko P.V., Fomin I.V., Avdeev S.N., Moiseev S.V., Yavorovskiy A.G., Brovko M.Yu. et al. Clinical characteristics of 1007 intensive care unitpatients with SARS-CoV-2 pneumonia. Clinical pharmacology and therapy. 2020;29(2):21–9. DOI: 10.32756/0869-5490-2020-2-21-29
5. Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B et al. ST-Segment Elevation in Patients with Covid-19 – A Case Series. New England Journal of Medicine. 2020;382(25):2478–80. DOI: 10.1056/NEJMc2009020
6. Zeng J-H, Liu Y-X, Yuan J, Wang F-X, Wu W-B, Li J-X et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020; [Epub ahead of print]. DOI: 10.1007/s15010-020-01424-5
7. Cizgici AY, Zencirkiran Agus H, Yildiz M. COVID-19 myopericarditis: It should be kept in mind in today’s conditions. The American Journal of Emergency Medicine. 2020;38(7):1547.e5-1547.e6. DOI: 10.1016/j.ajem.2020.04.080
8. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 2020; [Epub ahead of print]. DOI: 10.1001/jamacardio.2020.1096
9. Tung-Chen Y. Acute pericarditis due to COVID-19 infection: An underdiagnosed disease? Medicina Clínica. 2020;155(1):44–5. DOI: 10.1016/j.medcli.2020.04.007
10. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA et al. Fourth universal definition of myocardial infarction (2018). European Heart Journal. 2019;40(3):237–69. DOI: 10.1093/eurheartj/ehy462
11. Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (TakoTsubo or stress cardiomyopathy): A mimic of acute myocardial infarction. American Heart Journal. 2008;155(3):408–17. DOI: 10.1016/j.ahj.2007.11.008
12. Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2015;36(42):2921–64. DOI: 10.1093/eurheartj/ehv318
13. Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal. 2013;34(33):2636–48. DOI: 10.1093/eurheartj/eht210
14. Stefanini GG, Montorfano M, Trabattoni D, Andreini D, Ferrante G, Ancona M et al. ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes. Circulation. 2020;141(25):2113–6. DOI: 10.1161/CIRCULATIONAHA.120.047525
15. Khalid N, Chen Y, Case BC, Shlofmitz E, Wermers JP, Rogers T et al. COVID-19 (SARS-Cov-2) and the heart – An ominous association. Cardiovascular Revascularization Medicine. 2020;S1553838920302566. [Epub ahead of print]. DOI: 10.1016/j.carrev.2020.05.009
Review
For citations:
Chikhireva L.N., Chikhirev O.A., Pikin D.A., Bychkova O.P., Cherkashov A.M., Belenkov Yu.N. Myopericaditis as a late manifestation of the probable COVID-19. Kardiologiia. 2020;60(8):27-32. (In Russ.) https://doi.org/10.18087/cardio.2020.8.n1232